Biotech Smallcap Stocks’ Impact on the U.S. Market; Biodel Inc (NASDAQ:BIOD), Sunshine Biopharma, Inc. (OTCMKTS:SBFM), EnteroMedics Inc (NASDAQ:ETRM), Vycor Medical Inc (OTCMKTS:VYCO)

Expansive based growth in tech stocks and a bounce back in oil prices offered benchmarks some assistance during the final days of 2015. The technology sector was driven higher by gains in some of the larger companies. In the interim, oil prices moved up as investors predict that United States crude stockpiles to decrease, which in the end has helped energy stocks. Independently, a pick up in biotech stocks offered the markets some assistance with settling in the positive. Let’s take a look at how smallcap biotech stocks are contributing to the markets.

Biodel Inc (NASDAQ:BIOD) is a specialty biopharmaceutical company and works on the production and distribution of medicines for diabetes in the United States. On December 18th, the company announced that its Board of Directors agreed to a plan to explore tactical alternatives to understand further value from its pipeline assets and to save the large cash balance. On that day, Biodel Inc (NASDAQ:BIOD) traded 13.8 million shares and closed at its HOD of $0.307, up 13.7% from the open. On December 30th, BIOD has seen another rally with highs of $0.3631 by 11:30 A.M after an opening price of $3.09.

Sunshine Biopharma, Inc. (OTCMKTS:SBFM) is a pharmaceutical company whose goal is to research and produce drugs for the treatment of several forms of cancer. On December 28th, the company announced that it has acquired all of the remaining rights, title and interest in and to all global patents for the Company’s Adva-27a anticancer compound. On that same day, the stock saw a low of $0.0026 and moved up 353% to a high of $0.0118. On that same day, Sunshine Biopharma, Inc. (OTCMKTS:SBFM) traded 55.9 million share and the follow day saw 65.7 million shares trade with a weekly high of $0.0183.

EnteroMedics Inc (NASDAQ:ETRM), the maker of medical gadgets utilizing neuroblocking technology to help obesity, metabolic infections and other gastrointestinal issues, reported shareholder approval for three recommendations: a revision of the Organization’s Fifth Amended and Restated Certificate of Incorporation to impact an reverse split of its issued and outstanding shares of regular stock; an expansion in the quantity of shares of normal stock approved for issuance compelling after the reverse stock split; and the issuance of shares of the Organization’s common stock underlying convertible notes and warrants issued by EnteroMedics Inc (NASDAQ:ETRM) as per the terms of a securities purchase assertion dated November 4, 2015. Weeks later, the stock opened up at $0.12 and moved up as much as 32% to a high of $0.1586 by 11:46 A.M on December 30th.

Vycor Medical Inc (OTCMKTS:VYCO) has a goal to provide the medical community with new and groundbreaking therapeutic and surgical solutions. The Vycor Medical has a multitude of FDA-cleared medical drugs and technologies that are altering and improving lives every day. The company operates two business units: Vycor Medical and NovaVision, both of which adopt a minimally or non-invasive approach. In November, Vycor Medical Inc (OTCMKTS:VYCO) announced that it would be launching its European internet-delivered therapy suite at the 3rd European Conference of NeuroRehabilitation which works to improve vision for those who lost it because of certain conditions. Over the last few months, VYCO has seen lows of $0.551 and has seen a 131.67% difference with highs of $1.39. After hitting those lows back in mid December, shares of VYCO have begun to climb.  As of December 30th, prices have rebounded by as much as 58% following highs of $0.87 prior to the close.

Want more information on Biotech Stocks About To Go Up? CLICK HERE

Related News

Leave a Reply

Your email address will not be published. Required fields are marked *

Copyrıght 2015 All RIGHTS RESERVED.